Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

Parascript AccuDetect, designed to help radiologists in the early detection of hard-to-find breast cancers, gains acceptance for commercialization in the European Union on the heels of approval for sister product AccuDetect Galileo

Parascript , LLC, the image analysis and pattern recognition technology provider, announced that it received CE (Conformite Europeenne) Mark for AccuDetect ® Computer Aided Detection ( CAD ) software. The company makes this announcement on the heels of obtaining CE Mark for its AccuDetect Galileo Computer Aided Detection (CAD) software, which uses the integration of two independent CAD systems to create a robust CAD solution with improved lesion detection rates and low false marks.

As with AccuDetect Galileo Computer Aided Detection software, AccuDetect CAD performs a computerized second read of mammography images to help radiologists confirm that a suspicious area requires further investigation. AccuDetect CAD is unique in that it uses a different methodology to achieve high sensitivity and low false positive rates through the integration of several complimentary algorithms and a sophisticated voting scheme within a single CAD system. The two products complement each other and target unique customers and distribution channels.

"We are delighted to receive our second CE Mark, this time for AccuDetect CAD software for mammography," said Yuri Prizemin, director of product marketing for Parascript. "Parascript remains committed to raising the bar for next generation CAD systems, and we are pleased to be able to offer our AccuDetect to customers in the European Union."

Source: Parascript

Click on the link to see more Mammography Devices